Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Completed · Phase 3 · Has a placebo group

Conditions studied: Deep Vein Thrombosis, Pulmonary Embolism

In brief

The purpose of this study is to learn whether apixaban can prevent the blood clots in the leg (deep vein thrombosis) and lung (pulmonary embolism) that sometimes occur after hip replacement surgery and to learn how apixaban compares with enoxaparin in preventing these clots. The safety of apixaban will also be studied

Key facts

Study ID
NCT00423319
Run by
Bristol-Myers Squibb
People needed
5407
Starts
2007-03-01
Expected to finish
2009-09-01
Last updated by the study team
2014-05-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.